1. Quotes

    831-840 of 909 « 1 2 ... 81 82 83 84 85 86 87 ... 89 90 91 »
    1. Publisher: Los Angeles Times
      But I can't tell you how many nonfatal heart attacks are caused by this bursting, because we can't do the autopsy to look at the arteries.
      - Peter Libby in Vulnerable plaques could become easier to detect with new technologies
    2. Publisher: Los Angeles Times
      But if we can predict heart attacks, can we do anything about it? We will need studies to see if new drugs, stents or other treatments can improve outcome.
      - Gregg W. Stone in Vulnerable plaques could become easier to detect with new technologies
    3. Publisher: Ophthalmology Times
      Very often, this can be done by comparing change with change over time with a healthy group of individuals.
      - Robert N. Weinreb in Glaucoma progression: Monitor disease with multi-step process
    4. Publisher: Ophthalmology Times
      We don't necessarily need to look for both structural and functional change to be convinced that the patient has progression.
      - Robert N. Weinreb in Glaucoma progression: Monitor disease with multi-step process
    5. Publisher: WBNS 10TV
      We've raised over $15 million in equity funding so far from a variety of venture capital firms and from angel investors.
      - Thomas F. Barnish in Investors Shift Focus to Biotechnology (Imalux raised over $15 million)
    6. Publisher: Ophthalmology Times
      In some ocular diseases, the numbers of cones are decreased and, using this device, we are able to evaluate the status of the cells and see how well these cells are functioning-in vivo.
      - Gisèle Soubrane in Electromagnetic deformable mirror assists in retinal diagnostics
    7. Publisher: Michelson Diagnostics
      We will be applying for a CE-mark for the product enabling sale for clinical use in Europe, in the spring 2009 time-frame
      - Jon Holmes in Michelson Diagnostics to demonstrate prototype hand-held OCT Probe at BIOS 09
    8. Publisher: Michelson Diagnostics
      We have a lot of interest from clinicians who have seen the excellent quality of images produced by our existing EX1301 multi-beam OCT Microscope
      - Gordon Mckenzie in Michelson Diagnostics to demonstrate prototype hand-held OCT Probe at BIOS 09
    9. Publisher: theheart.org
      We are doing a high number of off-label-indication cases, patients and lesions are becoming more and more complex, with more calcification and much less guarantee that in 20 seconds with one balloon, you can have good apposition of the stent and a good job done. And in this case, we need to increase the level of accuracy at the time of implanting and at follow-up: OCT is a new possibility to obtain the best placement. This could be very important in the future.
      - Giulio Guagliumi in OCT imaging suggests low rates of uncovered/malapposed struts following DES for AMI
    10. Publisher: theheart.org
      Although it has greater resolution that IVUS, OCT can't assume that the absence of neointima means no endothelialization at a cellular level, and similarly, it cannot assume that the presence of tissue on struts is healthy, functional endothelium.
      - David Kandzari in OCT imaging suggests low rates of uncovered/malapposed struts following DES for AMI
    831-840 of 909 « 1 2 ... 81 82 83 84 85 86 87 ... 89 90 91 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Most Quoted Topics